Health Care/Hospital
Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China
SUZHOU, China and ROCKVILLE, Md., Nov. 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
2020-11-23 18:32
1962
Huami Corporation Reports Third Quarter 2020 Unaudited Financial Results
BEIJING, Nov. 23, 2020 /PRNewswire/ -- Huami Corporation (NYSE: HMI) today reported revenue ofRMB2.2 billion, or US$329.2 million; GAAP diluted net income per share ofRMB0.31 (US$0.05), or GAAP diluted net income per ADS of RMB1 .24 (US$0.18) for the third quarter endedSeptember 30, 2020. "Third ...
2020-11-23 17:10
9190
Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA™ Viral MagBead Kit
IRVINE, Calif., Nov. 23, 2020 /PRNewswire/ -- Zymo Research announced today that itsQuick-DNA/RNA™ Viral MagBead Kit was cleared for distribution to the European Union (EU) common market. Theproduct is designed for high-throughput purification of viral DNA and/or RNA from biological samples that ...
2020-11-23 14:05
2496
Picosun's medical ALD solutions enable safer surgeries
ESPOO, Finland, Nov. 23, 2020 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions, partners with prominent Chinese hospitals and researchers to apply medical ALD technology for safer surgical procedures. Picosun's biocompatible ...
2020-11-23 10:54
1344
Rewardz Empowers Employees with Joye - A Mental Wellness & Self-Care Offering
SINGAPORE, Nov. 23, 2020 /PRNewswire/ -- According to the World Health Organisation, COVID-19 has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health support continues to increase. It is evident that society and businesses must reco...
2020-11-23 10:00
2066
ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC
SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today announced that positive clinical data based on a pre-p...
2020-11-23 09:30
3772
CGTN: China calls for more inclusive development in post-COVID world
BEIJING, Nov. 23, 2020 /PRNewswire/ -- With COVID-19 still causing widespread damage across the world,China on Saturday called for concerted efforts from major economies to promote more inclusive development and improve global governance in the post-pandemic era.   Read the ori...
2020-11-23 09:09
2598
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowle...
2020-11-23 09:00
2396
Infinitus Harnesses eCommerce to Offer Greater Direct Selling Opportunities for Partners
GUANGZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Ahead of key eCommerce festivals such as 11.11 and Black Friday, Infinitus (China) Company Ltd ("Infinitus"), a purveyor of health products and solutions, has harnessed the power of social e-Commerce to open up new direct selling opportunities for ...
2020-11-23 09:00
2138
G20 Riyadh Summit: Release of Leaders' Declaration
RIYADH, Saudi Arabia, Nov. 23, 2020 /PRNewswire/ -- G20 Leaders endorsed their declaration at the end of their summit todayNovember 22, 2020, including agreements on steps to be taken to protect lives and shape a better future. "We, the G20 Leaders, meeting for the second time under the Saudi Pr...
2020-11-23 08:30
1503
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
SAN FRANCISCO and SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2020-11-23 08:00
5926
Firestorm Fire Protection PTY Announces Rebranding, Changes Name to United Safety
A leader in the fire protection space has unveiled a new name, logo, and look. EXTON, Pa., Nov. 22, 2020 /PRNewswire/ -- Kristian Bischoff, CEO and Managing Director announced as ofNovember 1st, 2020 that a company-wide rebranding had been completed. "When Firestorm was purchased by United Safe...
2020-11-23 07:00
1767
Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease
OMAHA, Ne., Nov.20, 2020 /PRNewswire/ -- Researchers within the School of Health and Kinesiology at theUniversity of Nebraska at Omaha (UNO) have found that a novel antioxidant can provide a number of health benefits for individuals with peripheral artery disease. The antioxidant specifically ta...
2020-11-20 23:07
2367
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange
HONG KONG, Nov. 20, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer medicines, today announced that the company was officially listed and it's shares commenced trading on the Main Board...
2020-11-20 21:09
13087
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease
RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy The Phase 3 study is expected to recruit up to 125 patients across approximately 40 U.S. clinical sites RHB-...
2020-11-20 21:00
5448
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting
Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients PLYMOUTH MEETING, Pa., Nov. 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely de...
2020-11-20 21:00
5808
Ortho's CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals
- Ortho's VITROS® SARS-CoV-2 antigen test can detect SARS-CoV-2 infection in asymptomatic individuals. - The low-cost VITROS antigen test can run up to 130 tests per hour and is a viable choice for frequent, high-throughput testing and monitoring of large community populations. RARITAN, N.J., N...
2020-11-20 20:00
1611
CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December
SHANGHAI, Nov. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, today announced that data from its global multiple myeloma program will be presented, including two oral presentations and one poster session, at the 62nd American Society of Hematology (ASH)...
2020-11-20 19:00
3455
Successful Day 1 of COMEUP 2020, with more than 50,000 accumulative online views, 7,500 pre-registrations, and 400,000 accumulative visits to the homepage
* COMEUP 2020: Day 1 (19 November) * Successful Day 1, with academic conferences in 'Digital healthcare' to 'Environment' * Day 1 afternoon sessions featured lectures and passionate discussions in 2 areas, 'Digital healthcare' and 'Environment' * World-famous experts in healthcare and clea...
2020-11-20 18:10
1702
Concord Medical Schedules 2020 Annual Meeting of Shareholders
BEIJING, Nov. 20, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...
2020-11-20 17:00
4673
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 330 media titles]
2025-01-18 03:30
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 304 media titles]
2025-01-18 17:00
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 295 media titles]
2025-01-14 21:00
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
Most Read
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
6877
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
6801
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
6796